Intensity Therapeutics, Inc. Common stock (INTS NASDAQ) stock market data APIs
$0.2368
-0.01(-4.2%)
as of September 15, 2025
Try our APIs with
free plan!
Intensity Therapeutics, Inc. Common stock Financial Data Overview
Price chart is built with
Anychart
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.
Prev. Close
0.2368
Open
0.2281
High
0.2373
Low
0.2133
52 wk Range
0.1853-4.1874
Market Cap
10 927 K
Shares Outstanding
47 058 K
EPS
-0.13
Beta
3.78
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Intensity Therapeutics, Inc. Common stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Intensity Therapeutics, Inc. Common stock data using free add-ons & libraries
Get Intensity Therapeutics, Inc. Common stock Fundamental Data
Intensity Therapeutics, Inc. Common stock Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Intensity Therapeutics, Inc. Common stock Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: 2025-08-07
- EPS/Forecast: -0.16
Get Intensity Therapeutics, Inc. Common stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Intensity Therapeutics, Inc. Common stock News
New
Stay updated with the stocks that are on the move in today's after-hours session.
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics. [postmarket] AFTER HOURS GAINERS TICKER CHANGE COMMENT THAR [https://www.char...
Intensity Therapeutics regains compliance with Nasdaq requirement
Intensity Therapeutics (NASDAQ:INTS [https://seekingalpha.com/symbol/INTS]) said [https://seekingalpha.com/pr/20197325-intensity-therapeutics-inc-regains-compliance-with-nasdaqs-minimum-stockholders-e...
Intensity Therapeutics GAAP EPS of -$0.13
* Intensity Therapeutics press release [https://seekingalpha.com/pr/20194119-intensity-therapeutics-reports-second-quarter-2025-financial-results-and-provides-corporate] (NASDAQ:INTS [https://seekin...
Intensity Therapeutics shareholders elect director and approve auditor at annual meeting
Intensity Therapeutics , Inc. (NASDAQ:INTS), a micro-cap biotech company currently valued at $8.36 million with shares trading at $0.33, held its annual meeting of stockholders via live webcast on Thu...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
